Function of erythropoietin?

NORCET 1 - 2020

Applied Physiology

Easy

Appeared in: NORCET 1 - 2020

Explanation

Erythropoietin (EPO) is the principal hormone that regulates red blood cell (RBC) production, a process called erythropoiesis.
It is produced primarily by the kidneys in response to tissue hypoxia (low oxygen levels).
EPO acts on the bone marrow to stimulate the maturation of erythroid progenitor cells into mature RBCs, thereby increasing the oxygen-carrying capacity of the blood.

Option A: The synthesis of White Blood Cells (WBCs), or leukopoiesis, is not regulated by erythropoietin.
Option C: The synthesis of platelets, or thrombopoiesis, is not regulated by erythropoietin.
Option D: Plasma is the non-cellular, liquid component of blood. It is not 'synthesized' in the same way as blood cells.

Visual 1: Diagram: The Erythropoietin Feedback Loop. This visual would show how low oxygen levels in the kidney stimulate EPO production, which in turn acts on the bone marrow to increase RBC count. The resulting increase in blood oxygen then provides negative feedback to the kidneys to decrease EPO production.
Visual 2: Flowchart: Hematopoiesis. This chart would illustrate the differentiation of a pluripotent hematopoietic stem cell into the common myeloid and lymphoid progenitors, and then further down into erythrocytes, leukocytes (neutrophils, lymphocytes, etc.), and platelets, highlighting the key stimulating factors for each lineage.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Function of Erythropoietin and Hematopoiesis as background academic context rather than a clinical decision trigger.
A critical clinical application is the use of recombinant human erythropoietin (e.g., Epoetin alfa) to treat anemia, particularly in patients with chronic kidney disease who cannot produce enough EPO on their own.
This treatment is also used for anemia caused by chemotherapy in cancer patients or certain treatments for HIV.
What if? A patient presents with an abnormally high red blood cell count (polycythemia) and high blood pressure, but lives at sea level and has no respiratory disease. A possible, though rare, cause could be an erythropoietin-secreting tumor (e.g., renal cell carcinoma), which leads to excessive and unregulated RBC production.

How to Approach the Question

Identify the key term in the question: 'erythropoietin'.
Analyze the word parts for clues. 'Erythro-' is a prefix referring to red or red blood cells (erythrocytes). '-poietin' comes from the Greek 'poiesis', meaning 'to make' or 'to form'.
Combining the parts suggests 'a substance that makes red blood cells'. This directly points to RBC synthesis.
Evaluate the other options by recalling the specific regulatory hormones for other blood components: thrombopoietin for platelets and colony-stimulating factors for white blood cells.
Eliminate 'plasma synthesis' as plasma is the liquid matrix, not a cell type produced via hematopoiesis.

Concept Tested & Keywords

QS24uZndxouE6ljfs0m_WF